Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

[Summary] 寡核酸药物研发商

思合基因是中国反义寡核酸新药研发的*企业,国家高新技术企业,专精特新中小企业。创始人是国家高层次人才,“万人计划”科技*王海盛博士,团队来自百济神州、Ionis等公司的前高管。思合基因突破反义核酸“卡脖子”技术壁垒,建立了具有自主知识产权的技术平台,针对感染、心衰、眼科、中枢神经系统等不同领域疾病开展新药研发,正在成为全球反义核酸药物的创新*。我们拥有国际一流的技术平台和充满激情的科研团队,旨在通过前沿科学为全球患者带来希望。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Financing History (3 rounds)

Manage
战略投资
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 2700万人民币
  • Investor: 百洋医药集团

honors, qualifications & industry associations

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 202.0642万(元)
Legal Representative: 王海盛
Date Established:
Credit Code: 91110108MA7D01JM5R
Registered Address: 北京市门头沟区平安路20号院6号楼4层

People who follow this company also follow

Competitors (Similar Companies)

“生命科学与集成医疗”
“一家集研发、生产、销售隐形牙齿矫正产品于一体的医疗器械企业”
“微知卓是一家生物医药技术研发商,主要发展生物医疗器械和细胞治疗等高端生物医药技术的研发与制造,利用干细胞分化技术,为用户提供肝损伤、急慢性肝衰竭等肝脏疾病的救护和康复治疗。”
手套 PVC手套 医用耗材 防护用品
医药 抗体 生物医药 新药研发
干细胞 再生医学 细胞治疗 CDMO
医药科技 医药创新 中医药 药物设计
“开发基于RNA干扰(RNAi)技术的核酸药物”
“创新药物研发商”
医药 医药中间体 原料药 药物研发
“专注于siRNA药物的开发”
生物科技/生物工程 生物科技
CDMO 抗肿瘤药 研发 医药
医药 放射性药物 研发 核素药物

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates

生活美容
客服
由百度提供